Gluskin Sheff & Assoc Inc Eli Lilly & CO Transaction History

Gluskin Sheff & Assoc Inc

$814 Million
Q3 2024

A detailed history of Gluskin Sheff & Assoc Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 7,110 shares of LLY stock, worth $5.46 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

7,110

Previous 7,364 3.45%

Holding current value

$5.46 Million

Previous $6.67 Million 5.52%

% of portfolio

0.77%

Previous 0.8%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $196,123 - $243,845	-254 Reduced 3.45%	7,110 $6.3 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $969,151 - $1.22 Million	-1,337 Reduced 15.37%	7,364 $6.67 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $662,671 - $886,561	-1,119 Reduced 11.4%	8,701 $6.77 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $2.12 Million - $2.5 Million	-4,034 Reduced 29.12%	9,820 $5.72 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $785,068 - $1.08 Million	-1,806 Reduced 11.53%	13,854 $7.44 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.83 Million - $2.45 Million	-5,224 Reduced 25.01%	15,660 $7.34 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.39 Million - $1.63 Million	-4,463 Reduced 17.61%	20,884 $7.17 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $131,513 - $153,240	409 Added 1.64%	25,347 $9.27 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.78 Million - $2.03 Million	6,012 Added 31.77%	24,938 $8.06 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.07 Million - $1.26 Million	3,854 Added 25.57%	18,926 $6.14 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $3.54 Million - $4.4 Million	15,072 New	15,072 $4.32 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Account

Gluskin Sheff & Assoc Inc Eli Lilly & CO Transaction History